{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:46:58Z","timestamp":1774288018806,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11306-020-01691-1","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T14:38:44Z","timestamp":1591195124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["New findings on urinary prostate cancer metabolome through combined GC\u2013MS and 1H NMR analytical platforms"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-770X","authenticated-orcid":false,"given":"Ana Rita","family":"Lima","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-8364","authenticated-orcid":false,"given":"Joana","family":"Pinto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6807","authenticated-orcid":false,"given":"Daniela","family":"Barros-Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9895-503X","authenticated-orcid":false,"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9884-4751","authenticated-orcid":false,"given":"M\u00e1rcia","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7395-5700","authenticated-orcid":false,"given":"Paula","family":"Guedes Pinho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"1691_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1373\/clinchem.2012.184598","volume":"59","author":"OA Aboud","year":"2013","unstructured":"Aboud, O. A., & Weiss, R. H. (2013). New opportunities from the cancer metabolome. Clinical Chemistry,59, 138\u2013146.","journal-title":"Clinical Chemistry"},{"key":"1691_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2105\/AJPH.86.5.726","volume":"86","author":"M Aickin","year":"1996","unstructured":"Aickin, M., & Gensler, H. (1996). Adjusting for multiple testing when reporting research results: The Bonferroni vs Holm methods. American Journal of Public Health,86, 726\u2013728.","journal-title":"American Journal of Public Health"},{"key":"1691_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1609\/icwsm.v3i1.13937","volume":"8","author":"M Bastian","year":"2009","unstructured":"Bastian, M., Heymann, S., & Jacomy, M. (2009). Gephi: An open source software for exploring and manipulating networks. ICWSM,8, 361\u2013362.","journal-title":"ICWSM"},{"key":"1691_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ijnurstu.2012.01.015","volume":"49","author":"L Berben","year":"2012","unstructured":"Berben, L., Sereika, S. M., & Engberg, S. (2012). Effect size estimation: Methods and examples. International Journal of Nursing Studies,49, 1039\u20131047.","journal-title":"International Journal of Nursing Studies"},{"key":"1691_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.aca.2011.09.015","volume":"707","author":"F Bianchi","year":"2011","unstructured":"Bianchi, F., Dugheri, S., Musci, M., Bonacchi, A., Salvadori, E., Arcangeli, G., et al. (2011). Fully automated solid-phase microextraction\u2013fast gas chromatography\u2013mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sediments. Analytica Chimica Acta,707, 197\u2013203.","journal-title":"Analytica Chimica Acta"},{"key":"1691_CR6","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/nprot.2011.375","volume":"6","author":"ECY Chan","year":"2011","unstructured":"Chan, E. C. Y., Pasikanti, K. K., & Nicholson, J. K. (2011). Global urinary metabolic profiling procedures using gas chromatography\u2013mass spectrometry. Nature Protocols,6, 1483.","journal-title":"Nature Protocols"},{"key":"1691_CR7","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., et al. (2018). MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Research,46, W486\u2013W494.","journal-title":"Nucleic Acids Research"},{"key":"1691_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1021\/pr301022e","volume":"12","author":"SO Diaz","year":"2013","unstructured":"Diaz, S. O., Barros, A. S., Goodfellow, B. J., Duarte, I. F., Carreira, I. M., Galhano, E., et al. (2013). Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine. Journal of Proteome Research,12, 969\u2013979.","journal-title":"Journal of Proteome Research"},{"key":"1691_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.clgc.2015.03.006","volume":"13","author":"A Fraga","year":"2015","unstructured":"Fraga, A., Ribeiro, R., Principe, P., Lopes, C., & Medeiros, R. (2015). Hypoxia and prostate cancer aggressiveness: A tale with many endings. Clinical Genitourinary Cancer,13, 295\u2013301.","journal-title":"Clinical Genitourinary Cancer"},{"key":"1691_CR10","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/ijc.31165","volume":"142","author":"P Gonzalez-Menendez","year":"2018","unstructured":"Gonzalez-Menendez, P., Hevia, D., Mayo, J. C., & Sainz, R. M. (2018). The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? International Journal of Cancer,142, 2414\u20132424.","journal-title":"International Journal of Cancer"},{"key":"1691_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.eururo.2010.01.035","volume":"58","author":"F Jentzmik","year":"2010","unstructured":"Jentzmik, F., Stephan, C., Miller, K., Schrader, M., Erbersdobler, A., Kristiansen, G., et al. (2010). Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. European Urology,58, 12\u201318.","journal-title":"European Urology"},{"key":"1691_CR12","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/ijc.28303","volume":"133","author":"K Jung","year":"2013","unstructured":"Jung, K., Reszka, R., Kamlage, B., Bethan, B., Stephan, C., Lein, M., et al. (2013). Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma. International Journal of Cancer,133, 2914\u20132924.","journal-title":"International Journal of Cancer"},{"key":"1691_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1593\/neo.13314","volume":"15","author":"AP Khan","year":"2013","unstructured":"Khan, A. P., Rajendiran, T. M., Ateeq, B., Asangani, I. A., Athanikar, J. N., Yocum, A. K., et al. (2013). The role of sarcosine metabolism in prostate cancer progression. Neoplasia (New York, NY),15, 491\u2013501.","journal-title":"Neoplasia (New York, NY)"},{"key":"1691_CR14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1021\/pr5011108","volume":"14","author":"D Kumar","year":"2015","unstructured":"Kumar, D., Gupta, A., Mandhani, A., & Sankhwar, S. N. (2015). Metabolomics-derived prostate cancer biomarkers: Fact or fiction? Journal of Proteome Research,14, 1455\u20131464.","journal-title":"Journal of Proteome Research"},{"key":"1691_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/metabo8010023","volume":"8","author":"AR Lima","year":"2018","unstructured":"Lima, A. R., Araujo, A. M., Pinto, J., Jeronimo, C., Henrique, R., Bastos, M. L., et al. (2018). GC-MS-based endometabolome analysis differentiates prostate cancer from normal prostate cells. Metabolites,8, 23.","journal-title":"Metabolites"},{"issue":"10","key":"1691_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41416-019-0585-4","volume":"121","author":"AR Lima","year":"2019","unstructured":"Lima, A. R., Pinto, J., Azevedo, A. I., Barros-Silva, D., Jeronimo, C., Henrique, R., et al. (2019). Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. British Journal of Cancer,121(10), 857\u2013868.","journal-title":"British Journal of Cancer"},{"key":"1691_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13547500410001668379","volume":"9","author":"JC Lindon","year":"2004","unstructured":"Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers,9, 1\u201331.","journal-title":"Biomarkers"},{"key":"1691_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1586\/14737159.2015.1069711","volume":"15","author":"G Lucarelli","year":"2015","unstructured":"Lucarelli, G., Rutigliano, M., Galleggiante, V., Giglio, A., Palazzo, S., Ferro, M., et al. (2015). Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer. Expert Review of Molecular Diagnostics,15, 1211\u20131224.","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"1691_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X19849978","author":"N MacKinnon","year":"2019","unstructured":"MacKinnon, N., Ge, W., Han, P., Siddiqui, J., Wei, J. T., Raghunathan, T., et al. (2019). NMR-based metabolomic profiling of urine: Evaluation for application in prostate cancer detection. Natural Product Communications. https:\/\/doi.org\/10.1177\/1934578X19849978.","journal-title":"Natural Product Communications"},{"key":"1691_CR20","doi-asserted-by":"publisher","first-page":"37275","DOI":"10.1038\/srep37275","volume":"6","author":"MS Monteiro","year":"2016","unstructured":"Monteiro, M. S., Barros, A. S., Pinto, J., Carvalho, M., Pires-Lu\u00eds, A. S., Henrique, R., et al. (2016). Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Scientific Reports,6, 37275\u201337275.","journal-title":"Scientific Reports"},{"key":"1691_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11306-017-1194-y","volume":"13","author":"C P\u00e9rez-Rambla","year":"2017","unstructured":"P\u00e9rez-Rambla, C., Puchades-Carrasco, L., Garc\u00eda-Flores, M., Rubio-Briones, J., L\u00f3pez-Guerrero, J. A., & Pineda-Lucena, A. (2017). Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia. Metabolomics,13, 52.","journal-title":"Metabolomics"},{"key":"1691_CR22","doi-asserted-by":"publisher","first-page":"18333","DOI":"10.3390\/ijms151018333","volume":"15","author":"N P\u00e9rtega-Gomes","year":"2014","unstructured":"P\u00e9rtega-Gomes, N., & Baltazar, F. (2014). lactate transporters in the context of prostate cancer metabolism: What do we know? International Journal of Molecular Sciences,15, 18333\u201318348.","journal-title":"International Journal of Molecular Sciences"},{"key":"1691_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11306-016-1046-1","volume":"12","author":"J Pinto","year":"2016","unstructured":"Pinto, J., Diaz, S. O., Aguiar, E., Duarte, D., Barros, A. S., Galhano, E., et al. (2016). Metabolic profiling of maternal urine can aid clinical management of gestational diabetes mellitus. Metabolomics,12, 105.","journal-title":"Metabolomics"},{"key":"1691_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A., & Oresic, M. (2010). MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics,11, 395.","journal-title":"BMC Bioinformatics"},{"key":"1691_CR25","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"H P\u00f3pulo","year":"2012","unstructured":"P\u00f3pulo, H., Lopes, J. M., & Soares, P. (2012). The mTOR signalling pathway in human cancer. International Journal of Molecular Sciences,13, 1886\u20131918.","journal-title":"International Journal of Molecular Sciences"},{"key":"1691_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature,457, 910\u2013914.","journal-title":"Nature"},{"key":"1691_CR27","doi-asserted-by":"publisher","first-page":"e22486","DOI":"10.1371\/journal.pone.0022486","volume":"6","author":"S Stabler","year":"2011","unstructured":"Stabler, S., Koyama, T., Zhao, Z., Martinez-Ferrer, M., Allen, R. H., Luka, Z., et al. (2011). Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS ONE,6, e22486.","journal-title":"PLoS ONE"},{"key":"1691_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/BMI.S6794","volume":"6","author":"K Stenman","year":"2011","unstructured":"Stenman, K., Stattin, P., Stenlund, H., Riklund, K., Gr\u00f6bner, G., & Bergh, A. (2011). H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples. Biomarker Insights,6, 39\u201347.","journal-title":"Biomarker Insights"},{"key":"1691_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jpba.2014.12.026","volume":"111","author":"W Struck-Lewicka","year":"2015","unstructured":"Struck-Lewicka, W., Kordalewska, M., Bujak, R., Yumba Mpanga, A., Markuszewski, M., Jacyna, J., et al. (2015). Urine metabolic fingerprinting using LC\u2013MS and GC\u2013MS reveals metabolite changes in prostate cancer: A pilot study. Journal of Pharmaceutical and Biomedical Analysis,111, 351\u2013361.","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"1691_CR30","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1038\/oncsis.2014.18","volume":"3","author":"E Tsouko","year":"2014","unstructured":"Tsouko, E., Khan, A. S., White, M. A., Han, J. J., Shi, Y., Merchant, F. A., et al. (2014). Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis,3, e103.","journal-title":"Oncogenesis"},{"key":"1691_CR31","doi-asserted-by":"publisher","first-page":"D402","DOI":"10.1093\/nar\/gkm957","volume":"36","author":"EL Ulrich","year":"2008","unstructured":"Ulrich, E. L., Akutsu, H., Doreleijers, J. F., Harano, Y., Ioannidis, Y. E., Lin, J., et al. (2008). BioMagResBank. Nucleic Acids Research,36, D402\u2013D408.","journal-title":"Nucleic Acids Research"},{"key":"1691_CR32","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.biocel.2012.08.013","volume":"44","author":"CV Vaz","year":"2012","unstructured":"Vaz, C. V., Alves, M. G., Marques, R., Moreira, P. I., Oliveira, P. F., Maia, C. J., et al. (2012). Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile. International Journal of Biochemistry & Cell Biology,44, 2077\u20132084.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"1691_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/ac8011544","volume":"81","author":"KA Veselkov","year":"2009","unstructured":"Veselkov, K. A., Lindon, J. C., Ebbels, T. M. D., Crockford, D., Volynkin, V. V., Holmes, E., et al. (2009). Recursive segment-wise peak alignment of biological 1H NMR spectra for improved metabolic biomarker recovery. Analytical Chemistry,81, 56\u201366.","journal-title":"Analytical Chemistry"},{"key":"1691_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cbpa.2017.01.001","volume":"36","author":"MR Viant","year":"2017","unstructured":"Viant, M. R., Kurland, I. J., Jones, M. R., & Dunn, W. B. (2017). How close are we to complete annotation of metabolomes? Current Opinion in Chemical Biology,36, 64\u201369.","journal-title":"Current Opinion in Chemical Biology"},{"key":"1691_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. (1956). On the origin of cancer cells. Science,123, 309\u2013314.","journal-title":"Science"},{"key":"1691_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00216-011-5098-9","volume":"401","author":"H Wu","year":"2011","unstructured":"Wu, H., Liu, T., Ma, C., Xue, R., Deng, C., Zeng, H., et al. (2011). GC\/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Analytical and Bioanalytical Chemistry,401, 635\u2013646.","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"1691_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-4939-1258-2_22","volume":"1198","author":"B Xi","year":"2014","unstructured":"Xi, B., Gu, H., Baniasadi, H., & Raftery, D. (2014). Statistical analysis and modeling of mass spectrometry-based metabolomics data. Methods in Molecular Biology,1198, 333\u2013353.","journal-title":"Methods in Molecular Biology"},{"key":"1691_CR38","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1039\/C4AN00690A","volume":"139","author":"P Zaragoza","year":"2014","unstructured":"Zaragoza, P., Ruiz-Cerda, J. L., Quintas, G., Gil, S., Costero, A. M., Leon, Z., et al. (2014). Towards the potential use of (1)H NMR spectroscopy in urine samples for prostate cancer detection. Analyst,139, 3875\u20133878.","journal-title":"Analyst"},{"key":"1691_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.aca.2017.09.019","volume":"991","author":"H Zheng","year":"2017","unstructured":"Zheng, H., Cai, A., Zhou, Q., Xu, P., Zhao, L., Li, C., et al. (2017). Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment. Analytica Chimica Acta,991, 68\u201375.","journal-title":"Analytica Chimica Acta"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01691-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-020-01691-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-020-01691-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T22:13:39Z","timestamp":1696198419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-020-01691-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1007\/s11306-020-01691-1","relation":{},"ISSN":["1573-3882","1573-3890"],"issn-type":[{"value":"1573-3882","type":"print"},{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have read the journal\u2019s policy on the disclosure of potential conflicts of interest and have none to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"70"}}